Styrene Oxide

HCID 7276CAS 96-09-3

Basic information

Standard SMILES
c1ccc(C2CO2)cc1
InChIKey
AWMVMTVKBNGEAK-UHFFFAOYSA-N
Molecular formula
C8H8O
Average molar mass
120.15 g/mol
Monoisotopic mass
120.05751488

Overview

Styrene Oxide can cause cancer according to an independent committee of scientific and health experts.

Names & identifiers

Preferred name
Styrene Oxide
IUPAC
2-phenyloxirane
English name
Styrene oxide
Molecular formula
C8H8O
Molecular weight
120.15

Names & synonyms

Styrene oxide2-Phenyloxirane96-09-3PhenyloxiraneEpoxystyrenePhenylethylene oxide1,2-EpoxyethylbenzeneStyrene epoxideStyryl oxidePhenethylene oxide1-PhenyloxiraneStyrene 7,8-oxide
Show more names
STO(±)-Styrene oxide
(Epoxyethyl)benzenePhenyl oxiraneEpoxyethylbenzene1-Phenyl-1,2-epoxyethaneBenzene, (epoxyethyl)-STYRENE-7,8-OXIDE1,2-Epoxy-1-phenylethaneoxirane, 2-phenyl-

Database identifiers

CAS
96-09-3
PubChem CID
7276
DTXSID
DTXSID2021286
ChEMBL
CHEMBL1605493
ChEBI
CHEBI:17907
UNII
9QH06NGT6O
EC Number
202-476-7
Nikkaji
J5.159D

Properties

Computed structural properties

XLogP
1.6
Topological polar surface area
12.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
1
Rotatable bonds
1
Heavy atoms
9

Experimental & physicochemical properties

Chemical Classes · 2 items

Hazardous Air Pollutants (HAPs)

Carcinogens

PolymersPlastics & Rubber -> Epoxides
LogP · 3 items

log Kow = 1.61

1.61

1.84

OdorSweet, pleasant
Density · 6 items

1.0523 at 61 °F (NTP, 1992) - Denser than water; will sink

1.0490 g/ cu cm at 25 °C

Styrene oxide (98 mole % pure) is available in USA with following specifications: density, 1.0490-1.0515 (25/25 °C); distillation range at 760 mm: fraction between 5 and 95% by vol shall boil within 3.0 °C range, which includes temp 194.1 °C; water, 0.25% by wt.

Relative density (water = 1): 1.05

1.0523

1.046 @25 °C

Viscosity1.99 cP at 20 °C

Physicochemical properties

Melting point
-37 °C · -37 °C (lit.)
Boiling point
194 °C · 194 °C (lit.)
Density
1.054 g/mL · 1.054 g/mL at 25 °C (lit.)
vapor density
4.14 · 4.14 (vs air)
vapor pressure
1 mm · <1 mm Hg ( 20 °C)
refractive index
20 · n20/D 1.535(lit.)

Safety & regulation

GHS classification

GHS Classification · 6 items

Danger

H312: Harmful in contact with skin [Warning Acute toxicity, dermal]

P203, P264+P265, P280, P302+P352, P305+P351+P338, P317, P318, P321, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

This chemical does not meet GHS hazard criteria for 4.3% (16 of 374) of reports.

Danger

H311 (15%): Toxic in contact with skin [Danger Acute toxicity, dermal]

Hazard information

Regulatory Information · 5 items

Chemical: Oxirane, phenyl-

Hazard Traits - Carcinogenicity; Dermatotoxicity; Hepatotoxicity and Digestive System Toxicity; Neurotoxicity; Ocular Toxicity; Reproductive Toxicity; Respiratory Toxicity

Status: Active Update: 10-06-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/14585

Phenylethylene oxide: Does not have an individual approval but may be used under an appropriate group standard

The New Jersey Worker and Community Right to Know Act requires public and private employers to provide information about hazardous substances at their workplaces. (N.J.S.A. 34:5A-1 et. seq.)

Other Safety InformationIMAP assessments - Oxirane, phenyl-: Environment tier I assessment
DOT LabelPoison
Fire Hazards · 2 items

This chemical is combustible. (NTP, 1992)

Combustible. Above 76 °C explosive vapour/air mixtures may be formed.

Fire Potential · 1 item

On ... basis /of flash point/, it presents hazard of flammability similar to that encountered with ... o-cresol, o-dichlorobenzene, naphthalene, phenol, and dimethylaniline. Definite hazard exists whenever ... /it/ is heated to temperatures at and above the flash point.

Health Hazards · 1 item

SYMPTOMS: Symptoms of exposure to this compound may include severe irritation of the skin and eyes, and skin sensitization. It can cause corrosion of tissues. Other symptoms may include burns, irritation of mucous membranes and upper respiratory tract, nausea, vomiting and headaches. Exposure may also cause central nervous system depression, hepatic lesions and pain to the eyes. Symptoms of exposure to a related compound include drying and cracking of the skin on contact, primary irritation to mucosal surfaces, fatigue, weakness, depression, unsteadiness, feeling of drunkenness, abnormal electroencephalograms and one case of toxic retrobulbar neuritis. Chronic exposure to a related compound has caused peripheral neuropathies (distal hypesthesia and decreased nerve conduction velocities).

Safety & protection

Fire Fighting · 2 items

Fires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. A water spray may also be used. (NTP, 1992)

Use powder, foam, carbon dioxide. In case of fire: keep drums, etc., cool by spraying with water. NO direct contact with water.

First Aid Measures · 4 items

Fresh air, rest.

Remove contaminated clothes. Rinse and then wash skin with water and soap.

First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.

Rinse mouth. Refer for medical attention .

First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Safe StorageSeparated from acids, bases and food and feedstuffs. Ventilation along the floor.
Firefighting Hazards... /Styrene oxide/ is a corrosive chemical that reacts vigorously with water ... .
Storage Conditions · 2 items

... PRECAUTIONS SHOULD BE TAKEN TO PREVENT EXCESSIVE PRESSURE UNDER STORAGE OR REACTION CONDITIONS & TO RELIEVE SUCH PRESSURE SHOULD IT OCCUR.

PRECAUTIONS FOR "CARCINOGENS": Storage site should be as close as practicable to lab in which carcinogens are to be used, so that only small quantities required for ... expt need to be carried. Carcinogens should be kept in only one section of cupboard, an explosion-proof refrigerator or freezer (depending on chemicophysical properties ...) that bears appropriate label. An inventory ... should be kept, showing quantity of carcinogen & date it was acquired ... Facilities for dispensing ... should be contiguous to storage area. /Chemical Carcinogens/

Toxicology

Body BurdenStyrene oxide has been detected in the venous blood of 4 workers exposed to styrene of unspecified purity(1).
Interactions · 1 item

Doses of 0.8 umol/egg styrene oxide (purity, 97%) dissolved in vegetable oil were injected into the air space of White-Leghorn "mittari" & SK 12 chicken eggs on day 3 of incubation. In addnl groups, 0.1 umol trichloropropylene oxide, an inhibitor of epoxide hydrolyase, was injected simultaneously with styrene oxide as a check on the effects of metabolism on embryotoxicity. Embryos were examined on day 14 of incubation. Styrene oxide treatment alone resulted in embryolethality & malformations; addition of trichloropropylene oxide to the styrene oxide treatment augmented these effects.

Ecotoxicity Values · 4 items

EC50; Species: Scenedesmus abundans (Green algae, 10+4 cells/mL); Conditions: freshwater, static, 22 °C; Concentration: 32000 ug/L for 96 hr; Effect: growth, general /97.0% purity/

LC50; Species: Daphnia magna (Water flea, age <24 hr neonate); Conditions: freshwater, renewal, 23.7 (23-24.5) °C, pH 8.34 (7.67-8.63), hardness 287.2 mgL CaCO3 (168-437 mg/L), alkalinity 174.2 mg/L CaCO3 (104-261 mg/L), dissolved oxygen 82.6% (75.9-95.3%); Concentration: 11600 ug/L for 48 hr (95% confidence interval: 10200-13100 ug/L) /97% purity/

LC50; Species: Pimephales promelas (Fathead minnow, age 30 days, length 17 mm, weight 0.082 g); Conditions: freshwater, flow through, 23.3 (22.5-24.8) °C, pH 6.9 (6.75-7.04), hardness 53.4 mgL CaCO3 (51.9-53.9 mg/L), alkalinity 40.5 mg/L CaCO3 (40-42 mg/L), dissolved oxygen 85.5% (72.9-92.3%); Concentration: 4540 ug/L for 96 hr /97% purity/

LC50; Species: Pimephales promelas (Fathead minnow, age 30 days, length 17 mm, weight 0.074 g); Conditions: freshwater, static, 22.3 (22-22.6) °C, pH 6.82 (6.53-7.12), hardness 53.2 mgL CaCO3 (49.9-57.9 mg/L), alkalinity 38 mg/L CaCO3 (31-42 mg/L), conductivity 120 (118-120) umhos/cm, dissolved oxygen 59.4% (25.6-73%); Concentration: 10700 ug/L for 96 hr /97% purity/

Environmental Fate · 3 items

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 53(SRC), determined from a water solubility of 3,000 mg/L(2) and a regression-derived equation(3), indicates that styrene-7,8-oxide is expected to have very high mobility in soil(SRC). Volatilization of styrene-7,8-oxide from moist soil surfaces is expected(SRC) given an estimated Henry's Law constant of 1.6X10-6 atm-cu m/mole(SRC), derived from its vapor pressure, 0.3 mm Hg(2), and water solubility, 3,000 mg/L(2). Styrene-7,8-oxide is not expected to volatilize from dry soil surfaces(SRC) based upon a vapor pressure of 0.3 mm Hg(2). Hydrolytic half-lives of 0.17, 28 and 40.9 hours have been reported for styrene-7,8-oxide at pH 3, 7, and 9, respectively(4). Hydrolysis is likely to be a more important fate than volatilization from moist soil or transport through soils, particularly in acidic soils(SRC). Styrene-7,8-oxide (100 mg/L) reached 80-82% of its theoretical BOD in 2 weeks using an activated sludge inoculum (30 mg/L) in the Japanese MITI test(5), suggesting that biodegradation is likely to be an important fate process for styrene-7,8-oxide; however, the test results might be for the hydrolysis product, styrene glycol(SRC).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 53(SRC), determined from a water solubility of 3,000 mg/L(2) and a regression-derived equation(3), indicates that styrene-7,8-oxide is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is expected for styrene-7,8-oxide(3) based upon an estimated Henry's Law constant of 1.6X10-5 atm-cu m/mole(SRC), derived from its vapor pressure, 0.3 mm Hg(2), and water solubility, 3,000 mg/L(2). Using this Henry's Law constant and an estimation method(3), volatilization half-lives for a model river and model lake are 64 hours and 23 days, respectively(SRC). According to a classification scheme(4), an estimated BCF of 3.5(SRC), from its log Kow of 1.61(5) and a regression-derived equation(6), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Hydrolytic half-lives of 0.17, 28 and 40.9 hours have been reported for styrene-7,8-oxide at pH 3, 7, and 9, respectively(7). Hydrolysis is likely to be a more important fate than volatilization from water or bioconcentration in aquatic organisms, particularly in acidic water(SRC). Styrene-7,8-oxide (100 mg/L) reached 80-82% of its theoretical BOD in 2 weeks using an activated sludge inoculum (30 mg/L) in the Japanese MITI test(8), suggesting that biodegradation is likely to be an important fate process for styrene-7,8-oxide; however, the test results might be for the hydrolysis product, styrene glycol(SRC).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), styrene-7,8-oxide, which has a vapor pressure of 0.3 mm Hg at 20 °C(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase styrene-7,8-oxide is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 3.2 days(SRC), calculated from its rate constant of 5.1X10-12 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Styrene-7,8-oxide does not contain chromophores that absorb at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).

Adverse EffectsNeurotoxin - Other CNS neurotoxin
Exposure RoutesThe substance can be absorbed into the body by inhalation, through the skin and by ingestion.

Regulatory information

Atmospheric Standards · 1 item

Listed as a hazardous air pollutant (HAP) generally known or suspected to cause serious health problems. The Clean Air Act, as amended in 1990, directs EPA to set standards requiring major sources to sharply reduce routine emissions of toxic pollutants. EPA is required to establish and phase in specific performance based standards for all air emission sources that emit one or more of the listed pollutants. Styrene-7,8-oxide is included on this list.

CERCLA Reportable Quantities · 1 item

Persons in charge of vessels or facilities are required to notify the National Response Center (NRC) immediately, when there is a release of this designated hazardous substance, in an amount equal to or greater than its reportable quantity of 100 lb or 45.4 kg. The toll free number of the NRC is (800) 424-8802. The rule for determining when notification is required is stated in 40 CFR 302.4 (section IV. D.3.b).

Safety data

PPE
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
wgk
3
tsca
TSCA listed
rtecs
CZ9625000
ridadr
UN 2810 6.1/PG 3
hs_code
29109000

Chemistry & industry

Pharmacology

Mechanism of Action · 2 items

The measurement of primary DNA damage caused by oxirane chemicals can be confounded by apoptotic-generated DNA autolysis. The apoptogenic potential of oxiranes requires knowledge of the relationship between the apoptotic threshold dose and cytotoxic dose for interpretation of DNA damage assays. This research determined the relationship between cytotoxic and apoptotic doses for seven simple oxiranes of varying structure. This relationship between cytotoxic and apoptotic thresholds was determined simultaneously in in vitro cell culture. L929 cells in log-phase growth were exposed to the oxiranes for 24 hr in 25 sq cm and then assayed fluorometrically in 96-well plates for Caspase 3. Viability was assessed using Trypan Blue exclusion and loss of Caspase 3 activity. Ranked apoptotic potency was: diepoxybutane (DEB)>styrene oxide (SO)>phenyl glycidyl ether (PGE)>epichlorhydrin (EPI)>glycidol (GLY)>epoxybutane (EB)>epoxycyclohexane (ECH). Relative cytotoxicity was significantly correlated (r(s)=0.86, p=0.02) with potencies: DEB>EPI>PGE>SO>GLY>EB>ECH. These structurally-diverse, simple oxiranes were all capable of inducing apoptosis at doses several-fold below their cytotoxic concentrations. Difunctionality and aromaticity were key predictors of potency for both. Caspase 3 activity was an accurate indicator of necrosis which correlated with Trypan Blue results.

Styrene oxide-DNA adducts have been found in several organs in mice and in cultured mammalian cells exposed to styrene oxide ... . A study of workers in a boat-making facility where styrene concentrations ranged from 1 to 235 mg/cu m (mean of 65.6 mg/cu m, or 13.3 ppm) found elevated levels of styrene oxide-DNA adducts in mononuclear cells ... . DNA adducts in rodents and humans appear to be similar. ... DNA and albumin adducts were found in the blood of plastics workers exposed to styrene oxide ... . Low levels of covalent binding of styrene oxide to DNA were observed in the stomachs of rats given styrene oxide orally ... .

Metabolism/Metabolites · 6 items

Urine of rats dosed with styrene (240 mg/kg), R-, S- and racemic styrene oxide (150 mg/kg) was analysed for mandelic acid enantiomers and for regioisomers and diastereomers of mercapturic acids by NMR spectrometry. ... R- and S-styrene oxide yielded predominantly R- and S-mandelic acid, respectively, racemic styrene oxide gave predominantly the R-enantiomer whereas styrene yielded almost racemic mandelate. The regioselectivity of mercapturic acid formation was very similar for styrene, R- and S-styrene oxide. These three species yielded a 2:1 mixture of N-acetyl-S-(1-phenyl-2-hydroxyethyl)cysteine (MA1) and N-acetyl-S-(2-phenyl-2-hydroxyethyl)cysteine (MA2). R-Styrene oxide gave higher conversion to mercapturic acids (28%) than the S-isomer (19% of the dose). However, R-styrene oxide yielded stereospecifically S,R-MA1 and R,R-MA2 whereas S-styrene oxide gave R,R-MA1 and S,R-MA2. Styrene yielded a mixture of diastereomeric mercapturic acids. The ratios of R,R-/S,R-isomers were 80:20 and 15:85 for MA1 and MA2, respectively. These data suggest that styrene is metabolized stereoselectively to S-styrene oxide as a major enantiomer in rat in vivo. This enantiomer has been reported to be less mutagenic than R-styrene oxide in vitro.

The major metabolic route for styrene in rats, mice, and humans involves conversion to styrene-7,8-oxide (SO). The purpose of this study was to evaluate blood SO, SO-hemoglobin (SO-Hb) adducts, and urinary metabolites in styrene-exposed human volunteers and to compare these results with data previously obtained for rodents. Four healthy male volunteers were exposed for 2 hr during light physical exercise to 50 ppm (13)C(8)-styrene vapor via a face mask. Levels and time profiles of styrene in exhaled air, blood, and urine (analyzed by GC) and urinary excretion patterns of mandelic acid and phenylglyoxylic acid in urine (analyzed by HPLC) were comparable to previously published volunteer studies. Maximum levels of SO in blood (measured by GC-MS) of 2.5-12.2 (average 6.7) nM were seen after 2 hr, i.e., in the first sample collected after exposure had ended. The styrene blood level in humans was about 1.5 to 2 times higher than in rats and 4 times higher than in mice for equivalent styrene exposures. In contrast the SO levels in human blood was approximately fourfold lower than in mice. The level of hydroxyphenethylvaline (determined by GC-MS-MS) in pooled blood collected after exposure was estimated as 0.3 pmol/g globin corresponding to a SO-Hb adduct increment of about 0.003 pmol/g and ppm hr. NMR analyses of urine showed that a major portion (> 95%) of the excreted (13)C-derived metabolites was derived from hydrolysis of SO, while only a small percentage of the excreted metabolites (< 5%) was derived from metabolism via phenylacetaldehyde. Signals consistent with metabolites derived from other pathways of styrene metabolism in rodents (such as glutathione conjugation with SO or ring epoxidation) were not detected.

The styrene-7,8-oxide (SO) burden in isolated lungs of male Sprague-Dawley rats and in-situ prepared lungs of male B6C3F1 mice ... /were investigated/. ... Styrene (ST) exposures ranged from 50 to 980 ppm (rats) and from 40 to 410 ppm (mice). SO was quantified from the effluent perfusate. Lungs of both species metabolized ST to SO. After a mathematical translation of the ex-vivo data to ventilation and perfusion conditions as they are occurring in vivo, a species comparison was carried out. At ST concentrations of up to 410 ppm, mean SO levels in mouse lungs ranged up to 0.45 nmol/g lung, about 2 times higher than in rat lungs at equal conditions of ST exposure. ... The species difference in the SO lung burden /appeared/ too small to consider the genotoxicity of SO as sufficient for explaining the fact that only mice developed lung tumors when exposed to ST. ...

... Understanding the relationship of the metabolism of styrene to its toxicity depends upon knowing the balance between the bioactivation of styrene to the epoxide by cytochromes P-450 and the detoxication of the oxide to the glycol by microsomal epoxide hydrolase. When hepatic and pulmonary microsomal preparations from non-Swiss albino (NSA) and Swiss (CD-1) mice were compared for their abilities to metabolize racemic, S- and R-styrene oxide to styrene glycol, enzymic activities were higher in liver than in lung. R-Styrene glycol formation was favored with racemic styrene oxide as the substrate. Only minor strain differences were found that could not account for the differences in reported susceptibility to styrene-induced toxicity. While the oxidation of styrene to styrene oxide was similar in male and female NSA mice, male hepatic microsomes were more active in the metabolism of the oxide to the glycol. Hepatic metabolism of styrene oxide to styrene glycol was inducible by butylated hydroxyanisole, whereas pulmonary metabolism was not. The data indicate that strain differences in susceptibility cannot be accounted for by this detoxication step, and there are sex differences in this reaction.

For more Metabolism/Metabolites (Complete) data for STYRENE-7,8-OXIDE (16 total), please visit the HSDB record page.

Styrene 7,8-oxide is a known human metabolite of styrene.

MeSH Pharmacological Classification · 2 items

Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included.

Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes.

Absorption, Distribution and Excretion · 5 items

Rodent species show marked differences in the distribution and regional density of Clara cells within the respiratory tract, as well as in their capacity to produce and eliminate styrene 7,8-oxide (SO)SO. A mode of action-based physiologically based pharmacokinetic (PBPK) model was developed to predict the concentration of ST and SO in blood, liver, and the respiratory-tract tissues, particularly in terminal bronchioles (target tisue), in order to conduct interspecies extrapolations and determine the extent to which there is a pharmacokinetic basis for the observed species specificity. This PBPK model has a multicompartment description of the respiratory tract and incorporates species-specific quantitative information on respiratory-tract physiology, cellular composition, and metabolic capacity. The model is validated against multiple data sets, including blood, liver, and whole lung tissue concentration of styrene (ST) and SO following multiple routes of exposure. The trend in neoplastic incidences in mice correlated well with model-estimated SO concentration in the terminal bronchioles. The PBPK model predicts a 10-fold lower SO concentration in the terminal bronchioles in rats compared to mice, which is consistent with the observed species sensitivity to the development of respiratory-tract neoplasms. The model-based analysis suggests that humans would be expected to be 100-fold less sensitive to ST-inducted lung tumors than mice, based on pharmacokinetic differences. Pharmacodynamic factors are also expected to contribute to species sensitivity, potentially augmenting pharmacokinetics-based differences.

When male rats were injected ip with 460 umol of styrene oxide with radioactive label, liver, brain, kidney, and duodenal contents of styrene oxide were higher than that in blood, lungs, and spinal cord, while ... /amount/ in CNS was small. Removal of injected compound was slow, between 3 and 6 hr after injection ... .

MAIN ROUTE OF EXCRETION OF STYRENE OXIDE METABOLITES IN ANIMALS IS BY WAY OF KIDNEY; IN RABBITS, ABOUT 80% OF SINGLE ORAL DOSE WAS EXCRETED IN URINE. ... /WHEN/ ... INJECTED IP OR INCUBATED IN VITRO /IT/ BINDS COVALENTLY TO MICROSOMES, PROTEIN & NUCLEIC ACID FRACTIONS OF RAT LIVER.

IT IS ABSORBED SLOWLY THROUGH SKIN.

For more Absorption, Distribution and Excretion (Complete) data for STYRENE-7,8-OXIDE (8 total), please visit the HSDB record page.

Uses & manufacturing

Uses · 6 items

Styrene oxide is used as a reactive plasticizer or diluent for epoxy resins; in the production of styrene glycol and its derivatives; as a raw material for the production of phenethyl alcohol used in perfumes; as a chemical intermediate for cosmetics, surface coatings, and agricultural and biological chemicals; and in the treatment of fibers and textiles.

Used as a reactive diluent for epoxy resins, a curing agent for polyesters and polyurethanes, a stabilizer (hydraulic fluids, chlorinated cleaning compounds, petroleum distillates, dielectric fluids, and acid-sensitive polymers and copolymers), and a lubricant for acetal polymers; [HSDB]

Plastic Composites Manufacturing [Category: Industry]

Highly reactive organic intermediate.

Used largely as intermediate in production of styrene glycol and its derivatives.

REACTIVE DILUENT FOR EPOXY RESINS; CHEM INTERMED FOR COSMETICS, SURFACE COATINGS, TREATMENT OF FIBERS & TEXTILES, AGRICULTURAL & BIOLOGICAL CHEMICALS

U.S. Production · 5 items

(1972) PROBABLY GREATER THAN 4.54X10+5 G

(1976) GREATER THAN 4.54X10+5 G

NO DATA (1992)

Production volumes for non-confidential chemicals reported under the Inventory Update Rule. [Table#4116]

Oxirane, phenyl- is listed as a High Production Volume (HPV) chemical (65FR81686). Chemicals listed as HPV were produced in or imported into the U.S. in >1 million pounds in 1990 and/or 1994. The HPV list is based on the 1990 Inventory Update Rule. (IUR) (40 CFR part 710 subpart B; 51FR21438).

Consumption Patterns(1976) It is estimated that 240,000 kg of beta-phenethyl alcohol were made from styrene oxide.
Methods of Manufacturing · 2 items

... /Styrene oxide/ is produced commercially either by the chlorhydrin route or by epoxidation of styrene with peroxyacetic acid.

It is prepared either via the chlorohydrin route or catalytically with hydrogen peroxide.

Formulations/PreparationsTypical product specifications are for 99% minimal purity and 01.-0.2% maximal water content
General Manufacturing Information · 3 items

Oxirane, 2-phenyl-: ACTIVE

Styrene oxide has been identified as an impurity in commercial samples of styrene chlorohydrin.

The commerial product is a racemic mixture of two optical isomers

Applications · 4 items

UsesStyrene oxide is is an important intermediate for organic synthesis and is widely used in organic synthesis, pharmaceutical preparation, and perfume production. For example, styrene oxide is added to hydrogen to produce monophenylethanol under the action of a catalyst. Styrene oxide has a wide range of uses, and can be used in floral fragrances for daily use, as well as in food. Styrene oxide is also an important intermediate for the synthesis of levamisole hydrochloride. L-imidazole hydrochloride is a broad-spectrum intestinal repellent that can be used by humans and animals.

UsesUsed as an intermediate in the production of styrene glycol and its derivatives; as a reactive dilutent in the epoxy resin industry; as a chemical intermediate for making bphenethyl alcohol, a fragrance material.

UsesA major (toxic) metabolite of Styrene (S687790), catalyzed by epoxide hydrolase.

General DescriptionStyrene oxide is a clear colorless straw-colored liquid with a sweet pleasant odor. (NTP, 1992)

Suppliers50 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
阿诺西(上海)生物技术有限公司400-1107768 15058188853 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
Shandong chuangyingchemical Co., Ltd.18853181302 · [email protected]

Additional notes

DefinitionChEBI: Styrene oxide is an epoxide that is oxirane in which one of the hydrogens has been replaced by a phenyl group. It has a role as a human xenobiotic metabolite. It derives from a hydride of a styrene.

Related reactions

248 records

Linked notes

Loading…